Specialty Pharmacy

Onions contain one of the highest concentrations of quercetin, a flavonoid extract with anti-proliferative effects.

Top news of the day from across the health care landscape.

Tofacitinib and Guselkumab show promise in patients with PsA.

Cannabinoid treatment may alleviate some symptoms of multiple sclerosis and IBS, in addition to chemotherapy-induced nausea.

How NS5A inhibitors block hepatitis C virus replication impacts treatment outcomes.

Overutilization of care can produce disparities between high- and low-income counties.

Novel vaccine modulates T cell responses in RA.

Compounds found in turmeric, red grapes, and apple peels block cancer cells from accessing nutrients need to grow and survive.

Phase 3 study seeks to further understand the mechanisms of ocrelizumab.

Achieving linkage to care and viral suppression among patients with HIV improves overall wellbeing and prevents new infections.

Publicly-funded cancer clinical trials are high impact and low cost, experts say.

Adcetris achieves superior outcomes in the treatment of CTCL.

Incidence of stroke was 2.17% per year in patients with cirrhosis compared with 1.11% in patients without cirrhosis.

Use of plant enzymes in bacterial cell factories may lead to effective anti-cancer drugs.

Top news of the day from across the health care landscape.

Screening for drug interactions is a challenge when a patient with HIV presents with several prescriptions.

Consumer opinions shape list of top rated pharmaceutical manufacturers based on products and services.

Exposure to secondhand smoke in children can lead to RA later in life.

CAR T-cell therapy shows significant progress towards a cure for multiple myeloma.

New findings show that becoming pregnant after breast cancer does not increase the risk of disease recurrence.

Scientist map all mutations that help HIV evolve away from PGT151.

Alecensa is a kinase inhibitor for the treatment of ALK-positive, metastatic non-small cell lung cancer.

HIV clinical staff should ask questions about each patient’s relationships and sexual activity regularly and redundantly.

Top news of the day from across the health care landscape.

Impairment is unrelated to how long patients have had MS, study finds.

Advances in treatment and care improved the 5-year survival rate after diagnosis by 26%.

Ibrutinib (Imbruvica) may extend survival for patients with leukemia.

Top articles of the week on Specialty Pharmacy Times.